Related Articles
Two consecutive days of treatment with liposomal cisplatin in non-small cell lung cancer
Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial
Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study